Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: China Clear all

345 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20042
20052
20069
20078
200811
200915
201010
201112
201211
201315
201414
201520
201619
201732
201829
201924
202033
202120
202219
202317
202411
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche26
Sun Yat-sen University23
Hunan Province Tumor Hospital15
AstraZeneca14
Eli Lilly and Company11
Bristol-Myers Squibb9
Fudan University9
Pfizer9
BeiGene8
Betta Pharmaceuticals Co., Ltd.8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung345
Lung Neoplasms43
Neoplasms15
Brain Neoplasms9
Adenocarcinoma6
Adenocarcinoma of Lung6
Breast Neoplasms6
Carcinoma6
Colorectal Neoplasms6
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 1 to 25 of 345. Each trial links to its page on Pharma Observatory.

245 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.